Literature DB >> 25797982

Progress toward measles elimination in kyrgyzstan.

Akbar Suvanbekov1, Gulzhan Kitarova2, Joshua A Reyer3, Nobuyuki Hamajima3.   

Abstract

Measles is one of the most severe infectious diseases of childhood, and one of the major causes of mortali-ty, especially in developing countries. Despite rare measles outbreaks in recent years, Kyrgyzstan seeks to show its commitment towards the global anti-measles campaign. The aim of this article is to summarize the scattered information on the recent status of measles, valid surveillance system, and measles elimination strategies in Kyrgyzstan, based on sources that include non-confidential but usually inaccessible governmental data. Infor-mation was extracted from the reports to the Ministry of Health and documents on the national surveillance system, in addition to outbreak cases extracted from the Republican Infectious Diseases Hospital's archive. To tackle the worsening measles situation in Kyrgyzstan, the Ministry of Health established the Republican Center for Immunoprophylaxis in 1994. Measles related death, which was rampant up until 1992, has not been registered since 2000 due to improved routine vaccination coverage, increasing from 88% in 1994 to 97% and over in 1997. The national surveillance system was modernized thanks to the World Health Organization, helping to detect measles cases and prevent major outbreaks. The system identified 222 cases in the outbreak of 2011, and the case cards in the hospital provided the findings of 69 admitted cases (42 infants, 22 children aged 1 to 14 years, and 5 aged 15 years or over), including 32 severe cases. This article provides a whole view on measles in Kyrgyzstan, which would be useful to control measles worldwide.

Entities:  

Keywords:  Kyrgyzstan; Measles; elimination; surveillance; vaccination

Year:  2015        PMID: 25797982      PMCID: PMC4361519     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  9 in total

1.  Recombinant measles viruses efficiently entering cells through targeted receptors.

Authors:  U Schneider; F Bullough; S Vongpunsawad; S J Russell; R Cattaneo
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Global eradication of measles: an epidemiologic and economic evaluation.

Authors:  Ann Levin; Colleen Burgess; Louis P Garrison; Chris Bauch; Joseph Babigumira; Emily Simons; Alya Dabbagh
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

3.  What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.

Authors:  Rebecca Martin; Steven Wassilak; Nedret Emiroglu; Amra Uzicanin; Sergei Deshesvoi; Dragan Jankovic; Ajay Goel; Nino Khetsuriani
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

Review 4.  Current status of measles in Japan.

Authors:  Tetsuo Nakayama; Jianhui Zhou; Motoko Fujino
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

Review 5.  Addressing the epidemiologic transition in the former Soviet Union: strategies for health system and public health reform in Russia.

Authors:  T H Tulchinsky; E A Varavikova
Journal:  Am J Public Health       Date:  1996-03       Impact factor: 9.308

6.  Improving the monitoring of immunization services in Kyrgyzstan.

Authors:  R M Weeks; F Svetlana; S Noorgoul; G Valentina
Journal:  Health Policy Plan       Date:  2000-09       Impact factor: 3.344

7.  Progress in reducing measles mortality--worldwide, 1999-2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-03-04       Impact factor: 17.586

8.  Global measles mortality, 2000-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-12-04       Impact factor: 17.586

9.  Global control and regional elimination of measles, 2000-2012.

Authors:  Robert T Perry; Marta Gacic-Dobo; Alya Dabbagh; Mick N Mulders; Peter M Strebel; Jean-Marie Okwo-Bele; Paul A Rota; James L Goodson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-07       Impact factor: 17.586

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.